Effectiveness and safety of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction: a meta-analysis.

Huang, Yun; Fang, Chongbo; Zhang, YuYu; Ma, Lili; Zhou, Hua; Ye, Honghua

Huang, Yun; Fang, Chongbo; Zhang, YuYu; Ma, Lili; Zhou, Hua; Ye, Honghua.

Affiliation

Huang Y; Department of Pharmacy.
Fang C; Department of Pharmacy.
Zhang Y; Department of Pharmacy.
Ma L; Department of Pharmacy.
Zhou H; Department of Pharmacy.
Ye H; Cardiology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.

J Cardiovasc Med (Hagerstown) ; 24(2): 123-131, 2023 02 01.

Article in En | MEDLINE | ID: mdl-36583980

Subject(s)

Heart Failure; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Humans; Angiotensin Receptor Antagonists/adverse effects; Antihypertensive Agents/pharmacology; Heart Failure/diagnosis; Heart Failure/drug therapy; Neprilysin; Receptors, Angiotensin; Sodium-Glucose Transporter 2 Inhibitors/adverse effects; Stroke Volume; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ventricular Dysfunction, Left / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Diagnostic_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: J Cardiovasc Med (Hagerstown) Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google